We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Lung Cancer

Journal Scan / Research · January 11, 2021

Mechanisms of Resistance to Selective RET TKIs in RET Fusion-Positive NSCLC

Annals of Oncology


Additional Info

Annals of Oncology
Mechanisms of Resistance to Selective RET Tyrosine Kinase Inhibitors in RET Fusion-Positive Non-Small-Cell Lung Cancer
Ann. Oncol 2020 Dec 01;31(12)1725-1733, JJ Lin, SV Liu, CE McCoach, VW Zhu, AC Tan, S Yoda, J Peterson, A Do, K Prutisto-Chang, I Dagogo-Jack, LV Sequist, LJ Wirth, JK Lennerz, AN Hata, M Mino-Kenudson, V Nardi, SI Ou, DS Tan, JF Gainor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading